UPenn Algorithm Prioritizes Cancer Mutations for Immunotherapy |
The neoantigens found in the patients’ tumors (non-small cell lung cancer) which were highly dissimilar were enriched for hydrophobic sequences and correlated with survival rates after the PD-1 checkpoint therapy. |
Read more
|